about
Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products-critical issues and concepts.Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trialBetween-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial.Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers.Current Scientific and Regulatory Approaches for Development of Orally Inhaled and Nasal Drug Products: Overview of the IPAC-RS/University of Florida Orlando Inhalation Conference.Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics of Orally Inhaled Drug Products.
@en
Pharmacokinetics of Orally Inhaled Drug Products.
@nl
type
label
Pharmacokinetics of Orally Inhaled Drug Products.
@en
Pharmacokinetics of Orally Inhaled Drug Products.
@nl
prefLabel
Pharmacokinetics of Orally Inhaled Drug Products.
@en
Pharmacokinetics of Orally Inhaled Drug Products.
@nl
P2093
P2860
P1433
P1476
Pharmacokinetics of Orally Inhaled Drug Products
@en
P2093
Juliet Rebello
Leslie Hendeles
Sandra Suarez
Stephen Horhota
P2860
P2888
P304
P356
10.1208/S12248-015-9736-6
P407
P577
2015-03-12T00:00:00Z
P6179
1005656257